ODDO BHF

Sword Group: H2 2023 Report of the Liquidity Agreement

Retrieved on: 
Thursday, March 28, 2024
AMF, ODDO BHF, Sale

Under the liquidity contract awarded by Sword Group to ODDO BHF, as of 31/12/2023, the following resources appeared on the account of liquidity:

Key Points: 
  • Under the liquidity contract awarded by Sword Group to ODDO BHF, as of 31/12/2023, the following resources appeared on the account of liquidity:
    - Number of transactions executed during the semester at purchase: 1,116
    - Number of transactions executed during the semester on sale: 1,080
    - Volume exchanged over the semester upon purchase: 34,943 shares for an amount of €1,319,183
    - Volume exchanged over the semester for sale: 38,733 shares for an amount of €1,455,889
    As a reminder, during the last balance sheet of 30/06/2023, the following resources appeared in the liquidity account:
    The implementation of the liquidity contract is carried out in accordance with AMF Decision No.
  • 2018-01 dated July 2, 2018, establishing liquidity contracts on equity securities as accepted market practice.

Commerzbank increases net profit for 2023 to €2.2 billion – Strategy is delivering

Retrieved on: 
Thursday, February 15, 2024
Rote, Commerzbank, NPE, German Finance Agency, DACH, Bank, TLA, Growth, ECM, Equity capital markets, Risk, Private, Central bank, MBank, European Central Bank, ODDO BHF, PSBC, RWA, Tax, Policy, Common equity, AT1, Annual, Executive officer, Research, Environment, Partnership, Cryptocurrency

On this basis, we will achieve a further increase in net profit for the current year”, said CEO Manfred Knof.

Key Points: 
  • On this basis, we will achieve a further increase in net profit for the current year”, said CEO Manfred Knof.
  • Net interest income rose by a third to €8.368 billion (2022: €6.459 billion), while net commission income was slightly down at €3.386 billion (2022: €3.519 billion).
  • Net profit also rose accordingly: compared to the previous year, net profit after taxes and minority interests increased by 55% to €2.224 billion (2022: €1.435 billion).
  • Revenues amounted to €1.106 billion (Q3 2023: €1.171 billion); the operating result totalled €508 million (Q3 2023: €644 million).

EQS-News: Commerzbank increases net profit for 2023 to €2.2 billion – Strategy is delivering

Retrieved on: 
Thursday, February 15, 2024
Rote, Commerzbank, NPE, German Finance Agency, DACH, Bank, TLA, Growth, ECM, Equity capital markets, Risk, Private, Central bank, MBank, European Central Bank, ODDO BHF, PSBC, RWA, Tax, Policy, Common equity, AT1, Annual, Executive officer, Research, Environment, Partnership, Cryptocurrency

On this basis, we will achieve a further increase in net profit for the current year”, said CEO Manfred Knof.

Key Points: 
  • On this basis, we will achieve a further increase in net profit for the current year”, said CEO Manfred Knof.
  • Net interest income rose by a third to €8.368 billion (2022: €6.459 billion), while net commission income was slightly down at €3.386 billion (2022: €3.519 billion).
  • Net profit also rose accordingly: compared to the previous year, net profit after taxes and minority interests increased by 55% to €2.224 billion (2022: €1.435 billion).
  • Revenues amounted to €1.106 billion (Q3 2023: €1.171 billion); the operating result totalled €508 million (Q3 2023: €644 million).

EQS-News: RENK Group AG and Triton decided for final private placement volume of RENK Group AG shares

Retrieved on: 
Tuesday, February 6, 2024
Triton, AMERICA, Landesbank Baden-Württemberg, ODDO BHF, KNDS, Ticker symbol, Goldman Sachs, J. P. Morgan, UniCredit, Frankfurt Stock Exchange, Security (finance)

to institutional investors in an accelerated bookbuilding process

Key Points: 
  • to institutional investors in an accelerated bookbuilding process
    The final offer will include 33,333,333 shares held by the selling shareholder Rebecca BidCo S.à r.l.
  • RENK Group AG shares are expected to be traded on the regulated market of the Frankfurt Stock Exchange (Prime Standard) starting February 7, 2024, under the Ticker Symbol R3NK.
  • Following the listing, Triton will continue to hold the majority of the shares of RENK Group AG.
  • The expected free float amounts to 27% (excluding around 6.67 million shares purchased by KNDS N.V. as cornerstone investor), creating a liquid market for shares of the RENK Group AG.

EQS-News: RENK Group AG and Triton initiate private placement

Retrieved on: 
Monday, February 5, 2024
Triton, Wellington Management Company, AMERICA, Landesbank Baden-Württemberg, ODDO BHF, KNDS, Exercise, Nexter Systems, Leopard 2, Ticker symbol, Greenshoe, Goldman Sachs, J. P. Morgan, UniCredit, KMW, EUR, Placement, Frankfurt Stock Exchange, Security (finance)

NOT FOR DISTRIBUTION OR ANNOUNCEMENT, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR ANNOUNCEMENT WOULD BE UNLAWFUL

Key Points: 
  • NOT FOR DISTRIBUTION OR ANNOUNCEMENT, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR ANNOUNCEMENT WOULD BE UNLAWFUL
    RENK Group AG and Triton initiate private placement of RENK Group AG shares and aim for listing on February 7, 2024
    Private placement of RENK Group AG shares held by the selling shareholder Rebecca BidCo S.à r.l.
  • Following the listing, Triton will continue to hold the majority of the shares of RENK Group AG.
  • Assuming full exercise of the greenshoe option, free float amounts to up to 30%, creating a liquid market for shares of the RENK Group AG.
  • The investment of KNDS into the RENK Group AG will further support the strategic international growth of RENK, strengthening its market position.

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

Retrieved on: 
Tuesday, January 16, 2024
ODDO BHF, DBV, NATIXIS, DBV Technologies, Cryptocurrency

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today issued the Half-Year report on its liquidity contract with NATIXIS ODDO BHF.

Key Points: 
  • DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today issued the Half-Year report on its liquidity contract with NATIXIS ODDO BHF.
  • Under the liquidity contract between DBV Technologies and NATIXIS ODDO BHF, the following assets appeared on the liquidity account as of December 31, 2023:
    When the liquidity contract with ODDO BHF was implemented, as of July 1, 2018, the following assets were included in the liquidity account:
    Over the period from July 1, 2023, to December 31, 2023, the following transactions were executed:
    376,978 shares and € 911,734.76 on purchases,
    303,962 shares and € 744,017.58 on sales.

Valneva to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference and Oddo BHF Forum

Retrieved on: 
Thursday, January 4, 2024
Conference, Euronext Paris, Saint-Herblain, CFO, FDA, Disease, ODDO BHF, Chikungunya, VLA

Saint-Herblain (France), January 4, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announces that members of its management team including Thomas Lingelbach, CEO and Peter Bühler, CFO will hold investor meetings during the 42nd Annual J.P. Morgan Healthcare Conference, January 8 – 10, 2024 in San Francisco and virtually at the Oddo BHF Forum on January 15,2024.

Key Points: 
  • Saint-Herblain (France), January 4, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announces that members of its management team including Thomas Lingelbach, CEO and Peter Bühler, CFO will hold investor meetings during the 42nd Annual J.P. Morgan Healthcare Conference, January 8 – 10, 2024 in San Francisco and virtually at the Oddo BHF Forum on January 15,2024.
  • Valneva’s CEO and CFO will notably discuss the Company’s advanced vaccine development pipeline, including its Lyme disease vaccine candidate VLA15 (Phase 3 fully enrolled, partnered with Pfizer), as well as the Company’s growing commercial business, which now includes recently FDA-approved1 IXCHIQ®, the world’s first licensed vaccine for prevention of disease caused by chikungunya virus, launching in early 2024.
  • To schedule a 1on1 investor meeting with Valneva, institutional investors and analysts can

Crossject announces initiation of coverage by ODDO BHF

Retrieved on: 
Tuesday, November 28, 2023
Report, Caregiver, Research, ODDO BHF, Alpha value, Injection, Patient, SCA, Development, Research report, Pharmaceutical industry

Dijon, France November 28, 2023, 07:30 CET -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company developing needle-free auto-injectors for emergency situations, announces initiation of coverage of its stock by analysts at independent financial group ODDO BHF.

Key Points: 
  • Dijon, France November 28, 2023, 07:30 CET -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company developing needle-free auto-injectors for emergency situations, announces initiation of coverage of its stock by analysts at independent financial group ODDO BHF.
  • All reports on Crossject prepared by analysts represent the views of those analysts, and are not necessarily those of Crossject.
  • ODDO BHF SCA and the issuer have agreed that ODDO BHF SCA will produce and disseminate investment recommendations on the issuer equity side as a service to the issuer.
  • This Research Report is for the use of eligible counterparties and professional clients of ODDO BHF SCA only.

Appointments within SCOR Investment Partners

Retrieved on: 
Friday, November 24, 2023
Marketing, Strategy, École polytechnique, Business, ODDO BHF, Investment, ENSAE, BNP Paribas Asset Management, Business development, Supply chain operations reference, Growth, Communication, Head, ParisTech, Management

Louis Bourrousse is appointed Chief Executive Officer of SCOR Investment Partners.

Key Points: 
  • Louis Bourrousse is appointed Chief Executive Officer of SCOR Investment Partners.
  • Under Louis Bourrousse’s leadership, SCOR Investment Partners’ executive committee brings together: Benjamin Ayache (Chief Operating Officer), Alexandre Jaeglé (Head of Business Development), Thibaut Lameyse (General Secretary), Marie-Suzanne Mazelier (Chief Investment Officer and Deputy Chief Executive Officer) and Eric Talleux (Chief Risk Officer and Deputy Chief Executive Officer).
  • François de Varenne, Group Chief Financial Officer and Deputy Chief Executive Officer of SCOR, comments: “These appointments, all internal promotions, bear witness to the deep talent pool we have assembled at SCOR Investment Partners.
  • Prior to joining SCOR Investment Partners, he spent five years at Groupama Asset Management.

EQS-News: RENK Group AG: RENK Group AG and Triton set price range for Initial Public Offering on the Frankfurt Stock Exchange

Retrieved on: 
Monday, September 25, 2023
IPO, Christian Schulz, AFRICA, Frankfurt Stock Exchange, UniCredit, Supervisory board, ODDO BHF, AMERICA, Goldman Sachs, Federal Financial Supervisory Authority, Prospectus, EUR, SEB, CFO, Growth, Mizuho, J. P. Morgan, 2013 German federal election, Security (finance), Triton

Susanne Wiegand, CEO of RENK Group AG, said: “Today is an important day on our path towards an IPO.

Key Points: 
  • Susanne Wiegand, CEO of RENK Group AG, said: “Today is an important day on our path towards an IPO.
  • Following the completion of the IPO, Triton will continue to hold a majority interest in RENK Group AG.
  • The free float, assuming placement of all offer shares, would be 27%, creating a liquid market for the shares of RENK Group AG.
  • RENK Group AG and Triton have each agreed to a lock-up period of six months after the shares are first traded on the Frankfurt Stock Exchange.